See more : The Flowr Corporation (FLWPF) Income Statement Analysis – Financial Results
Complete financial analysis of Lotus Eye Hospital and Institute Limited (LOTUSEYE.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Lotus Eye Hospital and Institute Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- ikuyo Co.,Ltd. (7273.T) Income Statement Analysis – Financial Results
- Partners Group Holding AG (PGHN.SW) Income Statement Analysis – Financial Results
- SEGMEN KARDESLER GIDA (SEGMN.IS) Income Statement Analysis – Financial Results
- Xi’an Global Printing Co., Ltd. (002799.SZ) Income Statement Analysis – Financial Results
- WuXi Biologics (Cayman) Inc. (WXIBF) Income Statement Analysis – Financial Results
Lotus Eye Hospital and Institute Limited (LOTUSEYE.NS)
About Lotus Eye Hospital and Institute Limited
Lotus Eye Hospital and Institute Limited, an eye hospital, provides eye care services in India. It offers services in the areas of refractive surgery, retina and uvea, cornea, glaucoma, paediatric and squint, computer vision syndrome, orbit and oculoplasty, neuro ophthalmology, and binocular vision. The company also provides cataract and intraocular lenses, as well as operates an eye bank. In addition, it offers ophthalmic fellowship training courses in cornea, glaucoma, retina, and anterior segments, as well as DNB teaching and training services. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was incorporated in 1997 and is based in Coimbatore, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 482.10M | 470.44M | 380.86M | 316.67M | 399.81M | 379.79M | 375.04M | 339.65M | 311.32M | 298.98M | 286.95M | 291.08M | 262.26M | 191.41M | 141.69M | 116.77M | 107.36M |
| Cost of Revenue | 346.44M | 219.85M | 188.24M | 156.53M | 189.49M | 181.79M | 178.46M | 167.80M | 144.90M | 151.89M | 79.69M | 84.84M | 84.90M | 28.32M | 43.17M | 23.94M | 21.42M |
| Gross Profit | 135.66M | 250.59M | 192.62M | 160.14M | 210.32M | 198.00M | 196.58M | 171.85M | 166.42M | 147.09M | 207.26M | 206.24M | 177.36M | 163.09M | 98.51M | 92.83M | 85.93M |
| Gross Profit Ratio | 28.14% | 53.27% | 50.58% | 50.57% | 52.60% | 52.13% | 52.42% | 50.60% | 53.46% | 49.20% | 72.23% | 70.85% | 67.63% | 85.20% | 69.53% | 79.50% | 80.04% |
| Research & Development | 0.00 | 488.00K | 831.00K | 498.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 21.80M | 20.53M | 5.17M | 5.21M | 6.68M | 8.33M | 9.75M | 8.34M | 9.19M | 26.59M | 9.69M | 7.69M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 12.78M | 13.47M | 9.90M | 3.31M | 12.78M | 11.57M | 8.12M | 4.85M | 1.38M | 4.21M | 4.71M | 6.55M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 34.58M | 34.00M | 15.06M | 8.52M | 19.46M | 19.89M | 17.87M | 13.19M | 10.57M | 30.80M | 40.92M | 37.17M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 11.46M | 4.36M | 3.52M | 4.57M | 5.12M | 5.24M | 3.53M | 155.38M | 169.77M | 208.91M | 203.61M | 198.51M | 155.28M | 93.74M | 69.27M | 53.69M |
| Operating Expenses | 35.11M | 204.53M | 158.29M | 144.86M | 194.76M | 193.35M | 182.74M | 173.14M | 165.95M | 169.77M | 208.91M | 203.61M | 198.51M | 155.28M | 93.74M | 69.27M | 53.69M |
| Cost & Expenses | 381.55M | 424.38M | 346.53M | 301.39M | 384.26M | 375.14M | 361.20M | 340.94M | 310.85M | 321.66M | 288.60M | 288.45M | 283.41M | 183.60M | 136.92M | 93.21M | 75.12M |
| Interest Income | 4.98M | 3.70M | 4.50M | 3.91M | 4.43M | 1.65M | 3.40M | 3.61M | 2.58M | 957.00K | 2.75M | 2.09M | 834.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 2.01M | 976.00K | 283.00K | 563.00K | 539.00K | 359.00K | 439.00K | 652.00K | 833.00K | 551.00K | 97.00K | 176.00K | 487.00K | 1.04M | 6.89M | 8.22M | 8.64M |
| Depreciation & Amortization | 37.28M | 29.81M | 25.01M | 23.30M | 24.97M | 27.97M | 33.71M | 34.41M | 44.34M | 47.39M | 35.11M | 37.00M | 39.98M | 26.39M | 25.65M | 16.65M | 10.06M |
| EBITDA | 79.42M | 88.37M | 68.09M | 44.60M | 41.15M | 36.39M | 47.53M | 32.63M | 45.01M | 25.93M | 36.47M | 44.53M | 18.83M | 34.20M | 30.42M | 38.84M | 42.30M |
| EBITDA Ratio | 16.47% | 18.56% | 17.42% | 13.58% | 11.93% | 10.59% | 14.60% | 11.60% | 14.99% | 8.59% | 12.71% | 14.44% | 7.18% | 17.87% | 21.47% | 34.43% | 39.40% |
| Operating Income | 100.55M | 50.32M | 36.43M | 14.30M | 16.18M | 4.64M | 13.84M | -1.30M | 473.00K | -22.68M | -1.65M | 2.63M | -21.15M | 7.81M | 4.77M | 23.56M | 32.24M |
| Operating Income Ratio | 20.86% | 10.70% | 9.57% | 4.52% | 4.05% | 1.22% | 3.69% | -0.38% | 0.15% | -7.58% | -0.58% | 0.90% | -8.07% | 4.08% | 3.37% | 20.17% | 30.03% |
| Total Other Income/Expenses | -60.41M | -53.37M | -42.49M | -41.87M | -3.11M | 2.06M | 3.19M | 1.74M | 3.94M | -4.01M | 3.07M | 1.91M | -1.30M | -1.04M | -5.19M | -9.62M | -8.64M |
| Income Before Tax | 40.14M | 56.52M | 40.94M | 19.92M | 14.56M | 6.28M | 17.02M | 4.02M | -205.00K | -22.24M | 998.00K | 4.54M | -21.64M | 6.77M | -415.00K | 15.22M | 23.60M |
| Income Before Tax Ratio | 8.33% | 12.01% | 10.75% | 6.29% | 3.64% | 1.65% | 4.54% | 1.18% | -0.07% | -7.44% | 0.35% | 1.56% | -8.25% | 3.54% | -0.29% | 13.03% | 21.99% |
| Income Tax Expense | 10.99M | 15.75M | 11.09M | 4.24M | 3.91M | -802.00K | -442.00K | -257.00K | -1.21M | -2.44M | 608.00K | 394.00K | 66.00K | 2.42M | 1.97M | 3.31M | 10.98M |
| Net Income | 29.15M | 40.78M | 29.85M | 15.68M | 10.65M | 7.08M | 17.47M | 4.27M | 1.01M | -19.81M | 390.00K | 4.15M | -21.71M | 4.35M | -2.39M | 11.91M | 12.62M |
| Net Income Ratio | 6.05% | 8.67% | 7.84% | 4.95% | 2.66% | 1.86% | 4.66% | 1.26% | 0.32% | -6.63% | 0.14% | 1.43% | -8.28% | 2.27% | -1.69% | 10.20% | 11.76% |
| EPS | 1.40 | 1.96 | 1.44 | 0.75 | 0.51 | 0.34 | 0.84 | 0.21 | 0.05 | -0.95 | 0.02 | 0.20 | -1.04 | 0.21 | -0.11 | 0.56 | 1.23 |
| EPS Diluted | 1.40 | 1.96 | 1.44 | 0.75 | 0.51 | 0.34 | 0.84 | 0.21 | 0.05 | -0.95 | 0.02 | 0.20 | -1.04 | 0.21 | -0.11 | 0.56 | 1.23 |
| Weighted Avg Shares Out | 20.82M | 20.80M | 20.80M | 20.80M | 20.80M | 20.80M | 20.79M | 20.80M | 20.80M | 20.80M | 20.80M | 20.80M | 20.80M | 20.80M | 20.80M | 20.80M | 10.26M |
| Weighted Avg Shares Out (Dil) | 20.82M | 20.80M | 20.80M | 20.80M | 20.80M | 20.82M | 20.79M | 21.14M | 20.80M | 20.80M | 20.80M | 20.80M | 20.80M | 20.80M | 20.80M | 20.80M | 10.26M |
Source: https://incomestatements.info
Category: Stock Reports